Literature DB >> 35584822

Age modifies both the maximal temperature and inflammatory response in patients with SARS-CoV-2 infection.

Colin J Crooks1, Joe West2, Joanne R Morling3, Mark Simmonds4, Irene Juurlink4, Steve Briggs4, Simon Cruickshank4, Susan Hammond-Pears5, Dominick Shaw6, Timothy R Card3, Andrew Fogarty7.   

Abstract

OBJECTIVE: To determine the maximal response of the temperature and inflammatory response to SARS-CoV-2 infection and how these are modified by age.
METHODS: Participants were patients admitted to hospital with SARS-CoV-2 infection. For each participant, the maximal temperature and serum C-reactive protein (CRP) were identified and stratified by age. In a secondary analysis, these were compared in patients treated before and after dexamethasone.
RESULTS: Mean maximal temperature varied by age (p<0.001; ANOVA) with the highest mean maximal temperature of 37.3°C observed in patients aged 30-49 years and decreasing maximal mean temperatures in the older age groups, with the lowest measure of 36.8°C observed in individuals aged 90-99 years. The mean maximal serum CRP also varied across age groups (p<0.001; ANOVA) and increased with age across all age categories from 34.5 mg/dL (95% confidence interval (CI) 22.0-47.0) for individuals aged 20-29 years to 77.6 mg/dL (95% CI 72.0-83.2) in those aged 80-89 years. After dexamethasone became standard treatment for COVID-19 pneumonia, mean maximal CRP decreased by 17 mg/dL (95% CI -22 to -11).
CONCLUSION: Age modifies both maximal temperature and systemic inflammatory response in patients with SARS-CoV-2 infection. © Royal College of Physicians 2022. All rights reserved.

Entities:  

Keywords:  COVID-19; age; infection; inflammation; temperature

Mesh:

Substances:

Year:  2022        PMID: 35584822      PMCID: PMC9135072          DOI: 10.7861/clinmed.2021-0603

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   5.410


  9 in total

1.  Inflation in epidemiology: "the proof and measurement of association between two things" revisited.

Authors:  G D Smith; A N Phillips
Journal:  BMJ       Date:  1996-06-29

Review 2.  Immunosenescence: a key player in cancer development.

Authors:  Jingyao Lian; Ying Yue; Weina Yu; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-11-10       Impact factor: 17.388

Review 3.  Fever in the elderly.

Authors:  D C Norman
Journal:  Clin Infect Dis       Date:  2000-07-25       Impact factor: 9.079

Review 4.  Understanding immunosenescence to improve responses to vaccines.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Immunol       Date:  2013-04-18       Impact factor: 25.606

Review 5.  Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention.

Authors:  Anna Aiello; Farzin Farzaneh; Giuseppina Candore; Calogero Caruso; Sergio Davinelli; Caterina Maria Gambino; Mattia Emanuela Ligotti; Nahid Zareian; Giulia Accardi
Journal:  Front Immunol       Date:  2019-09-25       Impact factor: 7.561

6.  Demographic perspectives on the mortality of COVID-19 and other epidemics.

Authors:  Joshua R Goldstein; Ronald D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-20       Impact factor: 11.205

7.  The role of C-reactive protein as a prognostic marker in COVID-19.

Authors:  Dominic Stringer; Philip Braude; Phyo K Myint; Louis Evans; Jemima T Collins; Alessia Verduri; Terry J Quinn; Arturo Vilches-Moraga; Michael J Stechman; Lyndsay Pearce; Susan Moug; Kathryn McCarthy; Jonathan Hewitt; Ben Carter
Journal:  Int J Epidemiol       Date:  2021-05-17       Impact factor: 7.196

8.  1918 Influenza: the mother of all pandemics.

Authors:  Jeffery K Taubenberger; David M Morens
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

9.  Dexamethasone in Hospitalized Patients with Covid-19.

Authors:  Peter Horby; Wei Shen Lim; Jonathan R Emberson; Marion Mafham; Jennifer L Bell; Louise Linsell; Natalie Staplin; Christopher Brightling; Andrew Ustianowski; Einas Elmahi; Benjamin Prudon; Christopher Green; Timothy Felton; David Chadwick; Kanchan Rege; Christopher Fegan; Lucy C Chappell; Saul N Faust; Thomas Jaki; Katie Jeffery; Alan Montgomery; Kathryn Rowan; Edmund Juszczak; J Kenneth Baillie; Richard Haynes; Martin J Landray
Journal:  N Engl J Med       Date:  2020-07-17       Impact factor: 91.245

  9 in total
  1 in total

1.  Doing what's necessary becomes doing what is possible.

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2022-05       Impact factor: 5.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.